Fatal Adverse Events Associated With Immune Checkpoint Inhibitors in Non–small Cell Lung Cancer: A Systematic Review and Meta-Analysis

Frontiers in Medicine

Ye Zhang¹  Yanxia Zhang²  Xiaomei Zhang²  Xiaolin Yu³  Ting Yao⁴ 

[1]Department of Personnel and Epidemiology, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, China

[2]Department of Respiratory, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, China

[3]Graduate School, Beijing University of Chinese Medicine, Beijing, China

[4]The 2nd Department of Pulmonary Disease in Traditional Chinese Medicine (TCM), China-Japan Friendship Hospital, Beijing, China

关键词: immune checkpoint inhibitors;    fatal adverse event;    non-small cell lung cancer;    incidence;    meta-analysis;   

DOI  :  10.3389/fmed.2021.627089

来源: Frontiers

【 授权许可】

CC BY